Metagenomi, Inc. Common Stock (MGX) — Capital Reinvestment Ratio
Metagenomi, Inc. Common Stock (MGX) has a Capital Reinvestment Ratio of 0.05x as of December 2022, meaning it reinvests 0% of its operating cash flow ($67.73 Million) in capital expenditures ($3.51 Million). Check MGX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Metagenomi, Inc. Common Stock Capital Reinvestment Ratio (2021–2022)
This chart tracks Metagenomi, Inc. Common Stock's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see MGX cash generation efficiency.
Annual Capital Reinvestment Ratio for Metagenomi, Inc. Common Stock (2021–2022)
Year-by-year Capital Reinvestment Ratio for Metagenomi, Inc. Common Stock from 2021 to 2022. See MGX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.47x | $29.72 Million | $13.98 Million | ▲ +292.9% |
| 2021 | 0.12x | $24.26 Million | $2.90 Million | — |